LAMINAR PHARMACEUTICALS SA
Ctra Valledemossa Km.7,4 C/ Issac Newton, S/N Block A, Planta 1, Puerta 3, Parc Bit Edificio Norte – Palma De Mallorca – 3665
VAT: ESA57451171
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, LAMINAR PHARMACEUTICALS SA has received € 2,985,285.0 for its participation in a total of 1 project(s) with a total cost of € 6,155,125.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-12-01 | 755179 | CLINGLIO | drug discovery · public health · mortality · pharmaceutical drugs · oncology | 2022-05-31 | coordinator | € 2,985,285.09 | € 6,155,125 | 1 | 13 | CORDIS ↪ |
LAMINAR PHARMACEUTICALS SA did not participate in complicit projects under Horizon Europe (2021-2027).
LAMINAR PHARMACEUTICALS SA did not participate in complicit projects under FP7 (2007-2013).